Product Information
TOPIRAMATE 15 MG SPRINKLE CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2294 per EA under NDC 59651045260. Its NADAC has been published 131 times since Apr 3, 2024.
FDA first approved this application on Sep 27, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651045260
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA215449FDA Approved
9/27/2023
TE Code
AB
On Market Since
9/27/2023
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 15 MG SPRINKLE CAP has been published 131 times since Apr 3, 2024, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2294 per EA |
|---|---|
| All-time high | $0.7713 (Jun 12, 2024) |
| All-time low | $0.2294 (Sep 23, 2026) |
| 52-week high | $0.3505 |
| 52-week low | $0.2294 |
| Median price | $0.3620 |
| Average price | $0.3882 |
| Largest weekly change | -30.2% (Nov 20, 2024) |
| Weeks tracked | 131 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TOPIRAMATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TOPIRAMATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 15 MG SPRINKLE CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 15 MG SPRINKLE CAP, manufactured by Aurobindo Pharma Limited, is $0.2294 per EA (NDC 59651045260), effective Sep 30, 2026.
How has the price of TOPIRAMATE 15 MG SPRINKLE CAP changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 15 MG SPRINKLE CAP has declined 63.6%. It has been tracked across 131 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 15 MG SPRINKLE CAP?
Since Apr 3, 2024, the NADAC for TOPIRAMATE 15 MG SPRINKLE CAP has ranged from a low of $0.2294 (Sep 23, 2026) to a high of $0.7713 (Jun 12, 2024), with a median of $0.3620 per EA.
Are there cheaper alternatives to TOPIRAMATE 15 MG SPRINKLE CAP?
No other NADAC-published product currently shares the active ingredient and strength of TOPIRAMATE 15 MG SPRINKLE CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOPIRAMATE 15 MG SPRINKLE CAP?
TOPIRAMATE 15 MG SPRINKLE CAP (NDC 59651045260) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.